Clinical Trial Update: Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/Phase 3 trial evaluating daily esomeprazole 40 mg for 7 days to treat acid reflux and sleep arousals in gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: Southern Arizona VA Health Care System | Conditions: Gastroesophageal Reflux Disease | Phase 2, Phase 3 | Status: UNKNOWN